Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Health Science Journal

  • ISSN: 1108-7366
  • Journal h-index: 51
  • Journal CiteScore: 10.69
  • Journal Impact Factor: 9.13
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Google Scholar citation report
Citations : 12326

Health Science Journal received 12326 citations as per Google Scholar report

Flyer image
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • CINAHL Complete
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • EMCare
  • OCLC- WorldCat
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
View More
Share This Page

Gender differences in Covid-19 vaccine patients: preliminary data

La centralita Della medicina interna nella gestione del paziente ospedalizzato (Proceedings of XXI Congress FADOI Campania)
Italy 2022

Ciarambino T*, Caruso G, Ciaburri F, De Michele F, Capasso F, Maffettone A, Perrella A D Avino M

Department of Internal Medicine, Marcianise Hospital, ASL Caserta, Italy
COVID 2 Department, Cardarelli Hospital, Naples, Italy
COVID 1 Department, Cardarelli Hospital, Naples, Italy
Internal Medicine Department, Monaldi Hospital, Naples, Italy
Internal Medicine Department, Cotugno Hospital, Naples, Italy

Scientific Tracks Abstracts: Health Sci J

Abstract:

Introduction: Vaccination is one of the greatest achievements of public health. Few studies on the COVID-19 vaccine by sex/ gender are reported. Aims: We evaluated the gender differences in COVID-19 vaccine patients. Methods: We included in our study, 300 Covid-19 patients enrolled in COVID Department, Cardarelli Hospital, and Naples. The mean age was 67±10 years (46% men), and 83% were Covid-19 vaccine patients. Results: We don’t report important differences by gender in Covid-19 vaccine patients. However, in our study, we described that more frequent symptoms were represented by fever (45%) and dyspnoea (50%) in female compared to male subjects. In particular, we reported that in female the report lung CT is typical (32%) compared to 28% in male subjects; 60% of male had two major comorbidity compared to 40% in female subjects. No differences we reported in drugs therapy, and we reported death in 1% of female compared to 3% of male subjects. Discussion: Our data are preliminary and describe no significantly differences by gender in Covid-19 vaccine patients. Future research should be designed in a gender-sensitive way to present and, where possible analyses, data by sex/gender to promote high vaccine coverage.

PDF HTML